Genus Capital Management »

United Therapeutics Corporation shares owned by Genus Capital Management

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Genus Capital Management from 13F filings

Historical chart of Genus Capital Management investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Genus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Genus Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.2M 4.4k 487.25
2024-12-31 $1.3M 3.6k 352.84

More positions owned by Genus Capital Management

NVIDIA Corporation (NVDA)
Rbc Cad (RY)
Ishares Tr Us Treas Bd Etf (GOVT)
Cisco Systems (CSCO)
Shopify Cl A Sub Vtg Shs (SHOP)
International Business Machines (IBM)
Corning Incorporated (GLW)
Toronto Dominion Bk Ont Com New (TD)
Gilead Sciences (GILD)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
Broadcom (AVGO)
Lam Research Corp Com New (LRCX)
Abbvie (ABBV)
Nutrien (NTR)

View all positions for Genus Capital Management

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Geode Capital Management
AQR Capital Management
Assetmark
Invesco
Norges Bank Investment Management
Dimensional Fund Advisors
Susquehanna International
Henderson Group
Citadel Advisors

View all funds holding United Therapeutics Corporation